Calorigenic Action of Glucagon
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, preclinical studies have revealed that glucagon may be harnessed for metabolic benefits, such as body weight loss in the context of obesity18.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [18]
In the citing paper
“Glucagon administration to rats was shown to promote a negative energy balance by increasing oxygen consumption18; an effect later attributed to an increase in non-shivering thermogenesis19.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [18]
Citations
Cites
THE EFFECTS OF IODIDES AND OTHER HALIDES GIVEN WITH THIOURACIL
Ferguson, J., & SELLERS, E. A. (1949) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03679-1 · Cited by 25
Cited by
NON‐SHIVERING THERMOGENESIS AND ITS THERMOREGULATORY SIGNIFICANCE
JANSKý, L. (1973) · Biological Reviews · doi:10.1111/j.1469-185x.1973.tb01115.x · Cited by 613
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
The metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
Tschöp, M. H., Finan, B., Clemmensen, C., Gelfanov, V., Perez-Tilve, D., Müller, T. D., & DiMarchi, R. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.021 · Cited by 235
“…and physiological mechanisms that are distinct from GLP-1, we were intrigued by reports from as early as the 1950s that detailed the chronic actions of the pancreatic hormone glucagon to increase lipolysis and thermogenesis (Davidson et al., 1957; Joel, 1966; Kuroshima and Yahata, 1979).”
BackgroundObesity: Current and potential pharmacotherapeutics and targets
Narayanaswami, V., & Dwoskin, L. P. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.015 · Cited by 186
“Moreover, glucagon infusion increases oxygen consumption in rats and increases resting energy expenditure in humans (Davidson et al., 1957; Nair, 1987).”
Ruiter, M., La Fleur, S. E., van Heijningen, C., van der Vliet, J., Kalsbeek, A., & Buijs, R. M. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1709 · Cited by 170
“(47) first showed a thermogenic effect of glucagon in rats.”
BackgroundRevisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
Hædersdal, S., Andersen, A., Knop, F. K., & Vilsbøll, T. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00817-4 · Cited by 176
Heim, T., & Hull, D. (1966) · The Journal of Physiology · doi:10.1113/jphysiol.1966.sp008088 · Cited by 124
Transforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
Glucagon-Induced Acetylation of Foxa2 Regulates Hepatic Lipid Metabolism
von Meyenn, F., Porstmann, T., Gasser, E., Selevsek, N., Schmidt, A., Aebersold, R. H., & Stoffel, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.014 · Cited by 130
Glucagon Control on Food Intake and Energy Balance
Al-Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163905 · Cited by 88
“, it was reported that glucagon injected subcutaneously increased oxygen consumption in rats [36].”
BackgroundGlucagon regulation of energy metabolism
Heppner, K. M., Habegger, K. M., Day, J. W., Pfluger, P. T., Pérez–Tilve, D., Ward, B., Gelfanov, V. M., Woods, S. C., DiMarchi, R. D., & Tschöp, M. H. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.019 · Cited by 97
“were the first to show that pharmacological infusion of glucagon into rats results in an increase in oxygen consumption [32,33].”
BackgroundTolerance to anorectic drugs: pharmacological or artifactual.
Levitsky, D., Strupp, B., & Lupoli, J. (1981) · Pharmacology, Biochemistry and Behavior · doi:10.1016/0091-3057(81)90128-3 · Cited by 85
Striking the balance: GLP-1/glucagon co-agonism as a treatment strategy for obesity
Hope, D. C. D., Vincent, M. L., & Tan, T. M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735019 · Cited by 81
“The enhanced metabolic rate observed with glucagon administration was shown early on in rodents and humans (36, 40).”
BackgroundPeptide‐based multi‐agonists: a new paradigm in metabolic pharmacology
Brandt, S. J., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Stemmer, K. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12837 · Cited by 65
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 74
Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
Marroquí, L., Alonso-Magdalena, P., Merino, B., Fuentes, E., Nadal, A., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 54
Kibler, R. F., Taylor, W. J., & Myers, J. D. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104976 · Cited by 53
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 53
Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells
Dicker, A., Zhao, J., Cannon, B., & Nedergaard, J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.5.r1674 · Cited by 50
“INJECTION OF GLUCAGON PREPARATIONS into intact animals was demonstrated some 40 years ago to lead to a thermogenic response (10, 11).”
BackgroundRational Design of Hybrid Peptides: A Novel Drug Design Approach
Wang, C., Yang, C., Chen, Y., Ma, L., & Huang, K. (2019) · Current Medical Science · doi:10.1007/s11596-019-2042-2 · Cited by 52
Oxyntomodulin analogue increases energy expenditure via the glucagon receptor
Scott, R., Minnion, J., Tan, T., & Bloom, S. R. (2018) · Peptides · doi:10.1016/j.peptides.2018.04.008 · Cited by 48
“As early as 1957, glucagon was shown to increase energy expenditure in rodents in both pair-feeding studies and through directly increasing oxygen consumption [23,24].”
BackgroundTwo daily glucagon injections induce nonshivering thermogenesis in Muscovy ducklings
Barré, H., Cohen-Adad, F., & Rouanet, J. L. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e616 · Cited by 56
Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Conceição-Furber, E., Coskun, T., Sloop, K. W., & Samms, R. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.868037 · Cited by 48
“In humans, acute infusion of glucagon (45 min to 210 min, 3-50 ng/kg/min) raises caloric expenditure on average by 200 kcal/day in lean and obese fasted subjects (51, 52, 68), and administration of glucagon increases metabolic rate in fasted preclinical models (60, 65, 66).”
BackgroundWinther, J. B., & Holst, J. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15693 · Cited by 47
“In 1957, Davidson et al. 9 described potential calorigenic actions of glucagon, appearing as increased energy expenditure.”
The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
Galsgaard, K. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124049 · Cited by 43
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
KUROSHIMA, A., Yahata, T., Habara, Y., & Ohno, T. (1984) · Journal of Thermal Biology · doi:10.1016/0306-4565(84)90042-1 · Cited by 31
Some aspects of the glucagon problem
Berthet, J. (1959) · The American Journal of Medicine · doi:10.1016/0002-9343(59)90229-3 · Cited by 27
Effect of Insulin and Glucagon on Tumour Growth
Salter, J., de Meyer, R., & BEST, C. H. (1958) · BMJ · doi:10.1136/bmj.2.5087.5 · Cited by 22
Self-citationFrampton, J., Izzi‐Engbeaya, C. N., Salem, V., Murphy, K. G., Tan, T., & Chambers, E. S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01223-y · Cited by 23
“In contrast to its effect on energy intake, the mean intervention effect of acute glucagon administration on energy expenditure was a moderate-to-large increase, which was consistent across all included studies, and congruent with prior research in rodents [12, 57, 58].”
ResultG Protein-Coupled Receptors as Regulators of Energy Homeostasis
Tao, Y., Yuan, Z., & Xie, J. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00001-7 · Cited by 21
More, V. R., Lao, J., McLaren, D. G., Cumiskey, A.-M., Murphy, B. A., Chen, Y., Previs, S., Stout, S., Patel, R., Satapati, S., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186586 · Cited by 21
Ruiter, M., Buijs, R. M., & Kalsbeek, A. (2006) · Current Diabetes Reviews · doi:10.2174/157339906776818596 · Cited by 23
“production, glucagon increases metabolic rate [9, 55, 92, 160], increases thermogenesis [93] and sympathetic ac-”
BackgroundPharmacological modulation of adaptive thermogenesis: new clues for obesity management?
Genchi, V. A., Palma, G., Sorice, G. P., D’Oria, R., Caccioppoli, C., Marrano, N., Biondi, G., Caruso, I., Cignarelli, A., Natalicchio, A., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02125-0 · Cited by 23
Vansant, G. A. A. M., Gaal, L. V., Acker, K. L. V., & Leeuw, I. D. (1991) · Metabolism · doi:10.1016/0026-0495(91)90082-8 · Cited by 16
Hope, D. C. D., & Tan, T. M.-M. (2023) · Peptides · doi:10.1016/j.peptides.2023.170962 · Cited by 16
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin, B. E., Duffin, K. L., & Konkar, A. A. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2023 · Cited by 17
Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease
Sangwung, P., Ho, J. D., Siddall, T., Lin, J., Tomás, A., Jones, B. J., & Sloop, K. W. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2023 · Cited by 15
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control
Lee, S. H., Park, H. Y., Yun, J. H., & Kyoung, E. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1645041 · Cited by 14
Characterization of LY3324954 a long-acting glucagon-receptor agonist
Roell, W. C., Coşkun, T., Kim, T., O’Farrell, L. S., Martin, J. A., Nason, S. R., Hernandez-Alamillo, J., Dhantu, S., Drucker, D. J., Sloop, K. W., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102073 · Cited by 12
“However, glucagon also regulates metabolic actions (as reviewed in [1]) including, amino acid catabolism, lipolysis [3 e 8], ketogenesis [9], fatty acid oxidation [10,11], satiety [12 e 16], thermogenesis [17,18], energy expenditure [19,20], and bile acid metabolism [21,22].”
FURTHER STUDIES ON THE RENAL ACTION OF GLUCAGON
Elrick, H., Whipple, N. E., Arai, Y., & HLAD, C. J. (1959) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-19-10-1274 · Cited by 11
Mavondo, G. A., Mkhwanazi, B. N., Mabandla, M. V., & Musabayane, C. T. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v13i5.13 · Cited by 10
Ruocco, C., Malavazos, A. E., Ragni, M., Carruba, M. O., Valerio, A., Iacobellis, G., & Nisoli, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106892 · Cited by 10
“It is worth emphasizing that EE was seen to increase in rats in a fasted state without a corresponding increase in blood glucose levels [252].”
Hormonal Thermogenesis of “Non-Norepinephrine” Type
Janský, L. (1978) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-5559-4_18 · Cited by 10
Heat stress alters hematological parameters in barrows and gilts
Rudolph, T. E., Roths, M. S., Freestone, A. D., White-Springer, S. H., Rhoads, R. P., Baumgard, L. H., & Selsby, J. T. (2024) · Journal of Animal Science · doi:10.1093/jas/skae123 · Cited by 15
KUROSHIMA, A., Ohno, T., & Doi, K. (1977) · Cellular and Molecular Life Sciences · doi:10.1007/bf02124089 · Cited by 9
Gut Peptide Agonism in the Treatment of Obesity and Diabetes
Grandl, G., Novikoff, A., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180044 · Cited by 11
Regulation of feeding and therapeutic application of bioactive peptides
Ueno, H., Zhang, W., & Nakazato, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108187 · Cited by 7
“Glucagon was reported to increase energy expenditure in rodents and humans through several mechanisms (Chan et al., 1984; Davidson, Salter, & Best, 1957; Nair, 1987).”
The effects of glucagon on hepatic mitochondrial metabolism in the pigeon, Columba livia
Ballantyne, J. S., John, T. M., & George, J. C. (1988) · General and Comparative Endocrinology · doi:10.1016/0016-6480(88)90188-8 · Cited by 7
Weinges, K. F., & Schwarz, K. (1960) · Journal of Molecular Medicine · doi:10.1007/bf01487752 · Cited by 7
Berthet, J. (1963) · Elsevier eBooks · doi:10.1016/b978-0-12-395549-4.50016-8 · Cited by 5
The metabolic actions of glucagon
Berthet, J. (1960) · Springer eBooks · doi:10.1007/978-3-642-86241-0_21 · Cited by 4
Beaser, S. B. (1958) · New England Journal of Medicine · doi:10.1056/nejm195809112591106 · Cited by 4
Glucagon and fetal growth in the rat
Tyson, J. E., Kinch, R. A. H., & Stevenson, J. A. F. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(68)90040-9 · Cited by 3
Metabolic Problems Involving the Pancreas, Choline, Insulin and Glucagon
BEST, C. H. (1959) · Novartis Foundation symposium · doi:10.1002/9780470719176.ch9 · Cited by 3
Self-citationZimmermann, T., Bleymehl, K., Haebel, P., Perens, J., Roostalu, U., Hecksher‐Sørensen, J., Doerr, J., Jarosch, S., Lam, D. D., Klein, H., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102326 · Cited by 4
“However, using a long-acting GCGR agonist we demonstrate for the first time that GCGR agonism neither affects neuronal activation nor food intake but leads to a body weight reduction attributed to an increase in energy expenditure upon subchronic treatment of DIO mice [47,48].”
Elmendorf, A. J., Furber, E. C., Lorentz, B., Mahler, C. A., Droz, B. A., Cosgrove, R., Poret, J. M., Knerr, P. J., Samms, R. J., & Flak, J. N. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102328 · Cited by 1
“…of glucose during such events as hypoglycemia and fasting [10], pharmacologic studies identified the ability of GCGR activation to increase energy expenditure and reduce food intake, which together induces rapid weight loss [11,12], effects that have been shown to translate to humans [13,14].”
GLP-1 Is Not Enough: Can Glucagon Fill the Energy Expenditure Gap?
Beji, S., & Caron, A. (2026) · Neuroendocrinology · doi:10.1159/000550812 · Cited by 1
Glucagon in Islet and Metabolic Regulation
Sandoval, D. A., Tong, J., & Alessio, D. D. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch7 · Cited by 1
Obesity, diabetes and energy metabolism
Pannacciulli, N., & Tataranni, P. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.1.1
Loyd, C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
17 Kallikrein-kinin system in diabetes
Kakoki, M., & Smithies, O. (2011) · De Gruyter eBooks · doi:10.1515/9783110252354.273
Glucagon Synthesis, Secretion, and Mechanisms of Action
Mohan, S., & Vella, A. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00005-6
Metadata
- Authors
- DAVIDSON, I. W. F., SALTER, J. M., & BEST, C. H.
- Affiliations
- University of Toronto (CA)
- ORCID
- DAVIDSON, I. W. F.
- Venue
- Nature
- Published
- 1957-11-23
- Volume
- 180
- Issue
- 4595
- Pages
- 1124-1124
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1977757297
- Cited by
- 66
- References
- 1
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- glucagon, metabolic rate, weight gain, fat content, protein content, moisture content, pair-fed control, energy intake, rats
- MeSH terms
- Energy Metabolism, Glucagon, Humans, Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.